The dispensing of psychotropic medicines to older people before and after they enter residential aged care
- PMID: 32045014
- DOI: 10.5694/mja2.50501
The dispensing of psychotropic medicines to older people before and after they enter residential aged care
Abstract
Objective: To examine the prevalence of psychotropic medicine dispensing before and after older people enter residential care.
Design: Retrospective national cohort study; analysis of Registry of Senior Australians (ROSA) data.
Setting, participants: All concession card-holding residents of government-subsidised residential aged care facilities in Australia who entered residential care for at least three months between 1 April 2008 and 30 June 2015.
Main outcome measures: Proportions of residents dispensed antipsychotic, benzodiazepine, or antidepressant medicines during the year preceding and the year after commencing residential care, by quarter.
Results: Of 322 120 included aged care residents, 68 483 received at least one antipsychotic (21.3%; 95% CI, 21.1-21.4%), 98 315 at least one benzodiazepine (30.5%; 95% CI, 30.4-30.7%), and 122 224 residents at least one antidepressant (37.9%; 95% CI, 37.8-38.1%) during their first three months of residential care; 31 326 of those dispensed antipsychotics (45.7%), 38 529 of those dispensed benzodiazepines (39.2%), and 25 259 residents dispensed antidepressants (19.8%) had not received them in the year preceding their entry into care. During the first three months of residential care, the prevalence of antipsychotic (prevalence ratio [PR], 3.37; 95% CI, 3.31-3.43) and antidepressant dispensing (PR, 1.05; 95% CI, 1.04-1.07) were each higher for residents with than for those without dementia; benzodiazepine dispensing was similar for both groups (PR, 1.01; 95% CI, 0.99-1.02).
Conclusions: Dispensing of psychotropic medicines to older Australians is high before they enter residential care but increases markedly soon after entry into care. Non-pharmacological behavioural management strategies are important for limiting the prescribing of psychotropic medicines for older people in the community or in residential care.
Keywords: Antidepressive agents; Antipsychotic agents; Dementia.
© 2020 AMPCo Pty Ltd.
Comment in
-
Prescribing psychotropic medications in residential aged care facilities.Med J Aust. 2020 Apr;212(7):304-305. doi: 10.5694/mja2.50562. Epub 2020 Mar 22. Med J Aust. 2020. PMID: 32200558 No abstract available.
References
-
- Westbury JL, Gee P, Ling T, et al. RedUSe: reducing antipsychotic and benzodiazepine prescribing in residential aged care facilities. Med J Aust 2018; 208: 398-403. https://www.mja.com.au/journal/2018/208/9/reduse-reducing-antipsychotic-...
-
- Westbury J, Gee P, Ling T, et al. More action needed: psychotropic prescribing in Australian residential aged care. Aust N Z J Psychiatry 2018; 53: 136-147.
-
- Royal Commission into Aged Care Quality and Safety. Restrictive practices in residential aged care in Australia (Background paper 4). May 2019. https://agedcare.royalcommission.gov.au/publications/Documents/backgroun... (viewed Aug 2019).
-
- Bradshaw SA, Playford ED, Riazi A. Living well in care homes: a systematic review of qualitative studies. Age Ageing 2012; 41: 429-440.
-
- NHS England. Optimising treatment and care for people with behavioural and psychological symptoms of dementia: a best practice guide for health and social care professionals. 2017. http://medicine.exeter.ac.uk/media/universityofexeter/medicalschool/pdfs... (viewed Aug 2019).
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous
